Muutke küpsiste eelistusi

E-raamat: Ovarian Cancer

Edited by (Division of Gynecologic Oncology, Stanford University School of Medicine, USA)
  • Formaat: PDF+DRM
  • Ilmumisaeg: 22-Aug-2025
  • Kirjastus: CRC Press
  • Keel: eng
  • ISBN-13: 9781040444047
  • Formaat - PDF+DRM
  • Hind: 31,19 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Raamatukogudele
  • Formaat: PDF+DRM
  • Ilmumisaeg: 22-Aug-2025
  • Kirjastus: CRC Press
  • Keel: eng
  • ISBN-13: 9781040444047

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This volume is the first of a new series dedicated to the historical developments in topics that are central to gynecological cancers.



This volume is the first of a new series dedicated to the historical developments in topics that are central to gynecological cancers. The six essays on ovarian cancer included here provide context from the perspective of experts in the field, illustrating what is required for the development and realization of medical innovation: (i) time consuming, decades-long basic research of the tumor genome and cancer cell biology, which may then set the basis for dramatic accelerations of recent therapeutic options; and (ii) the diligent assessment and fine-tuning of surgical techniques and concepts of patient prehabilitation and rehabilitation.

Preface

Contributors

1 Early Detection of Ovarian Cancer: An Update

Chae Young Han, Zhen Lu, Karen H. Lu, Jacob S. Bedia,

Anna Lokshin, Karen S. Anderson, Charles W. Drescher,

Steven Skates, and Robert C. Bast, Jr.

2 History of Cytoreductive Surgery in Ovarian Cancer Treatment

Alex A. Francoeur, Robert Bristow, and Jill Tseng

3 Hereditary Breast and Ovarian Cancer: A Historical Perspective

Payal D. Shah and Susan M. Domchek

4 History of PARP Inhibitors

Malte Renz and Jonathan S. Berek

5 History and Current Role of Immunotherapy in Ovarian Cancer Treatment

Stephanie Chow and Oliver Dorigo

6 The History and Current Role of Perioperative Care and Prehabilitation in
Ovarian Cancer

Marlene Misu Lee and Jalid Sehouli

Index
Malte Renz, MD, PhD, is an Attending Physician in Gynecologic Oncology and Principal Investigator in the Department of Gynecology with Center for Oncological Surgery at the Charité Universitätsmedizin Berlin.